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At Risk for Huntington's Disease
HD is a genetically caused brain disorder that causes uncontrollable bodily movements and robs
people's ability to walk, talk, eat, and think. The final result is a slow, ugly death. Children of parents
with HD have a 50-50 chance of inheriting the disease. There is no cure or treatment.
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FRIDAY, OCTOBER 1 8, 2019

Are we failing to stop Huntington’s disease by
ignoring ‘natural’ remedies, alternative therapies,
and repurposed drugs?
This article is Part 2 of a two-part series.
Because Huntington’s disease is so devastating and intractable, many affected
individuals and presymptomatic gene carriers like me have chosen to take
substances outside the pharmaceutical mainstream to try to forestall the inevitable
onset or worsening of symptoms.
The reason: 26 years after the discovery of the huntingtin gene, despite significant
progress in understanding the disease, there is no effective therapy or cure.
In Part 1 of this series, Robert Pacifici, Ph.D., the chief scientific officer for CHDI
Foundation, Inc., discussed the immense progress made in HD research and the
optimistic prospects for developing therapies. CHDI is the largest nonprofit effort
aimed at defeating HD.
Only two drugs addressing symptoms of HD have been approved by the U.S.
Food and Drug Administration (FDA) – Xenazine in 2008 and the similar,
improved drug Austedo in 2017. Both treat the involuntary movements in HD
(chorea) but do not attack the causes or halt progression of this fatal disorder.
(Click here to read more.)
Physicians also prescribe medications – nonspecific for HD – to alleviate the
difficult behavioral and psychiatric symptoms. Those drugs also have no effect on
progression.
Trying supplements
My mother died of HD in 2006 at age 68. As I desperately witnessed the disease’s
inexorable onslaught on her mind and body, I embarked on a controversial
“treatment now” program of unproven but certainly not quackish supplements, the
Huntington’s Disease Drug Works (HDDW) regimen developed by veteran HD
physician LaVonne Goodman, M.D.
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Starting in 2005, I introduced the supplements into my diet in steps. I worked up
to a daily routine in which I took 75 grams of trehalose, a sugar that seems to help
the brain clear cellular debris; 600 mg of medical-grade coenzyme Q-10 (which I
had taken on and off since 1996); two g of omega-3 oil; two g of blueberry
extract; and ten g of medical-grade creatine. (Click here to read more.)
For several years I participated as a subject in an HDDW online observational
study, performing cognitive tests on a home computer. In this very small study,
several early or midstage HD-affected people showed stabilization or
improvement. Late-stage patients did less well, continuing to progress with the
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disease. The study was too small for its results to be applicable to the general HD
population. (Click here to read more.)
I was the only presymptomatic gene carrier in the trial. Afterwards, I continued
the regimen on my own, but regularly consulted with Dr. Goodman.
In 2014, I stopped coenzyme Q-10 and creatine after clinical trials proved them
ineffective. Recently, in place of expensive high-grade omega-3 pills, I’m eating
more fish. Annually, I’ve spent thousands of dollars on supplements – none
covered by health insurance.
I have also sought to lead a healthy lifestyle, including intellectual and social
enrichment. Doctors and researchers encourage this and have pointed out that it
could be part of why I have long passed my mother’s age of onset, although there
is no scientific proof (Click here to read more).
The HDDW program and the clinical trials for coenzyme Q-10 and creatine were
the most formal testing of supplements. HD-affected individuals have tried and/or
discussed a range of other substances, including injections of live fetal shark cells,
the amino acid cysteine, medical marijuana, and the highly popular – but
potentially harmful – marijuana and hemp extract cannabidiol (CBD), usually by
drinking an oil.

Above, CBD products in a Los Angeles, CA, grocery store (photo by Deceptitom
[CC BY-SA 4.0 {https://creativecommons..org/licenses/by-sa/4.0}]). Below, the
supplements I have taken (photo by Gene Veritas, aka Kenneth P. Serbin)
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One group of advocates has also pushed for a clinical trial of methylene blue, a
dye under study as a possible way to alleviate a variety of medical conditions.
In our recent interview, Dr. Pacifici and I delved into whether CHDI and the HD
community are failing to defeat the disease by ignoring these types of alternative
approaches, including so-called “natural” remedies and repurposed drugs. The
video of our interview is posted at the end of this article.
HD-specific drugs needed
Citing the increased interest in HD in the pharmaceutical industry (discussed in
Part 1), Dr. Pacifici said that CHDI would assist any company aiming to test an
HD drug, as long as it’s safe, tolerable, and backed with enough resources to do a
careful clinical trial.
“It’s wonderful that there’s this diversity of folks that have assets and try and
come into the field, as long as they’re credible and well-thought-out,” he said.
However, because of HD’s genetic cause and complexity, CHDI has stressed that
drugs for halting disease progression must be “new chemical entities” and HDspecific.
Dr. Pacifici pointed to an example: difficulties with sleep, a serious symptom of
HD. The HD field must consider: “What are the things that are probably going to
happen out there anyway, because there’s a big market for sleep medications
versus the things that are very specific to HD, that if we don’t do them, they’re not
going to get done?”
Don’t expect to win the jackpot
The need for unique HD drugs, and the overall history of drug discovery, point to
the fact that so-called “natural” approaches and repurposing of other drugs will
not result in effective treatments, Dr. Pacifici asserted.
The alleviation of Dr. Pacifici’s own suffering from familial Mediterranean fever
(FMF, discussed in Part 1) resulted from the discovery of the drug colchicine, “a
natural thing from the crocus flower” already in use to treat gout. Such a scenario
is atypical, he explained.
“Obviously, I didn’t just win the Lotto,” Dr. Pacifici said. “I won the Mega
Millions with the fact that I happen to be treated by an existing drug. It’s pretty
rare.”
curehd.blogspot.com/2019/10/are-we-failing-to-stop-huntingtons.html
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The HD community should not expect such an outcome, he said.
“Obviously the thing that’s wonderful when that does happen is that there’s no
path that’s shorter from a discovery to a treatment,” he continued. “But the effect
has to be pretty overwhelming.”
Indeed, colchicine “completely stopped” the recurrent abdominal pain and fever
of FMF.
“You can imagine,” he said, “that observation’s a little harder to make in
Huntington’s disease, given the slow progression of the disease, given the myriad
of symptoms.”

Robert Pacifici, Ph.D. (photo by Gene Veritas)
Is ‘natural’ better?
The notion of “natural” products is a bit “artificial,” Dr. Pacifici pointed out.
“People, first of all, seem to think that something that’s ‘natural’ is better,” he
said. “There are plenty of horrible poisons like ricin that are natural, and if you
take them, they kill you. It’s ‘organic,’ and it’s ‘natural.’ That doesn’t mean it’s
good for you!”
We discussed a clinical trial for an eye disease using liquid from the resin of the
mastic tree from the Greek island of Chios, as reported by New York
Times columnist Frank Bruni. For thousands of years, people have used the resin
to address many types of health problems. The trial seeks to test whether the
liquid can repair damaged nerves in the eye, with potentially positive implications
for people with Alzheimer’s disease and other neurological conditions.
Dr. Pacifici said that, in such a study, scientists need to know the exact chemical
makeup of the substance and, in the case of a possible HD treatment, determine
whether that makeup is any different from other compounds CHDI has tested.
In the case of the mastic tree, scientists also need to ensure that weather conditions
and the conditions of the tree do not alter the makeup of the resin. Also, the
testing of the substance needs to be “reproducible,” he explained.
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That the compound in the liquid comes from a natural source is irrelevant, he
added, because scientists can produce such compounds in a lab.
Clinical trials are expensive, costing hundreds of millions of dollars, Dr. Pacific
observed. Ultimately, CHDI and HD researchers need to avoid “taking empty
shots on goal that we could have predicted up front had no chance of working.”
Millions of experiments
Not long after its founding in 2003, CHDI did a project to ensure that the HD field
did not miss a possible remedy among existing drugs and other substances, some
of them natural. According to Dr. Pacifici, the foundation worked with a small
firm that had a library of all FDA-approved drugs and also substances such as
vitamins and other generally safe items, including some shown to be safe and
tolerable in Phase 1 clinical trials.
“We tested all of those,” Dr. Pacifici recalled, referring to the entire library. “In
fact, we tested all of those at multiple concentrations. In fact, we tested all of
those at multiple concentrations with each other, in pairwise fashion [two drugs at
a time].”
Carried out in cells, the tests ran into the millions, he said.
“But we found nothing that suggested, ‘Yeah, there’s the Mega Millions hit or
combination of things that should go forward,'” he said.
The massive experiment confirmed the need for a unique, HD-specific type of
medicine that could be delivered to the brain safely over a long period of time,
thus attacking the specific problems caused by the disease, Dr. Pacifici observed.
Through Enroll-HD, the CHDI-sponsored global study of HD-affected individuals
and their families, CHDI tracks unusual data from visits to HD clinics that might
suggest follow-up to discover further clues for developing drugs.
The CBD ‘craze’
As a September 29 CNN documentary reported, in the United States production
and use of CBD for health reasons has boomed in the last six years. The
unregulated proliferation of CBD-containing products such as tinctures, foods,
and oils has left the public with little reliable information on the risks, including
items with harmful impurities.
“The CBD craze that we’re in, I think, is unprecedented really in the history of
medicine,” Donald Abrams, M.D., a leading cannabis researcher, said in the
broadcast. “It’s a compound that has gotten way ahead of any research to support
the claims that are being made.”
Dr. Pacifici, who’s studied the issue closely, echoed these
concerns. Tetrahydrocannabinol (THC), CBD, and other marijuana-based
compounds are “enjoying their moment in the sun” because of legalization for
recreational and medical use in some states, although not federally, he observed.
“It’s kind of the flavor of the month, if you will.”
Only one approved CBD drug
CBD is a “real compound,” he explained.
However, there is only one FDA-approved drug made from CBD, Epidiolex,
manufactured by the British firm GW Pharmaceuticals. Epidiolex was shown to
be safe and efficacious in the treatment of two types of childhood epilepsy.
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GW Pharmaceuticals had to run “through the same paces as any other drug
substance,” Dr. Pacifici remarked. “They happened to get it out of the marijuana
plant. That’s fine. I don’t care where it comes from. But it’s highly purified and
highly quantified so that they know exactly what’s in there and what’s not in there
and the purity of it.”
No other CBD product has been tested in a clinical trial.
In Dr. Pacifici’s view, because of the lack of quality control and regulatory
approval in the making of CBD products, a critical question remains: “Are people
who are experimenting with it actually getting real, pure CBD?” In some cases,
the products do not even contain CBD, or have an incorrect concentration.

CBD not yet tested for HD
Could CBD potentially treat Huntington’s disease?
“The short answer is, we don’t know,” he asserted. “I can’t tell you of the number
of fantastic ideas that I’ve had. Wonderful ideas, that I sit down, I think, ‘I’ve had
this eureka moment.’ Until you test it, and you find out that biology is more
complicated than you thought.”
Scientists, he said, know about CBD’s “pharmacology” – its function, effects, and
where it gets into the body. “Is it something that could potentially have a
beneficial effect? Sure. But has it been properly tested, especially in HD?
Absolutely not.”
Many researchers are currently focusing on CBD for HD, and they have
developed some very reasonable hypotheses, he said.
“To my mind, none of them, yet, have reached a level of evidence where
somebody wants to go spend a hundred million dollars or more on a trial to see if
it’s actually efficacious,” he said. “Maybe they will.”
Insufficient evidence on methylene blue
Regarding methylene blue, Dr. Pacifici observed that research is currently
insufficient, “so I don’t think any of us can say definitively that it will work or it
won’t work.”
“Isolated examples” show that it might be efficacious, but that’s not enough
“evidence to actually run a full-blown human clinical trial,” he explained.
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Produced by HD community members in 2016, The Blue Solution video suggests
that families can consult their doctors about methylene blue.
However, Dr. Pacifici cautioned against this approach.
“A lot of times people have said things like, ‘Well, as long as it doesn’t do
anything bad, why not take it,’” he remarked. “I think that’s a little bit dangerous.
First of all, you never really know whether or not something is safe and welltolerated until it’s tested.
“There are examples of opportunity costs. There are people who were on Co-Q 10
who were not allowed to participate in other, real trials because they were loaded
up with Co-Q 10. So, the idea that ‘it’s probably safe, and I’ll take it in case it is
good,’ I wouldn’t certainly advise somebody to go just based on that limited
amount of evidence.”
Diet and lifestyle
I asked Dr. Pacifici why so little research has focused on HD and diet and whether
it should.
“It doesn’t surprise me that people are curious about this,” he said, citing the
example of Lorenzo’s Oil, a nutrition-based treatment developed for
adrenoleukodystrophy, a deadly genetic brain disorder rarer than HD.
“In fact, we’re very careful,” he said of CHDI’s mission. “One of the reasons we
say that we’re trying to accelerate ‘therapies’ for HD – we don’t say accelerate
‘drugs’ – is because we don’t know what shape that therapy could take. We want
to be deliberately inclusive. In fact, I wouldn’t even limit it to diet. I would say
‘lifestyle.’”
He recalled the research of Jenny Morton, Ph.D., who works with transgenic HD
mice and sheep. Dr. Morton observed in an experiment that HD mice had erratic
sleep schedules – as do HD-affected people. She placed them with normal mice,
giving them sleeping and wakeup pills, and gave them things only at night, a
mouse’s normal time for activity.
“She was able to show that those mice now absolutely were back to their regular
rhythm – they had no choice – and actually it was very beneficial for them,” Dr.
Pacifici noted. “They actually even lived longer.”
Keeping our eye on the ball
With the advent of historic clinical trials such as the Roche Phase 3 gene-silencing
program, “we’re at a stage now where there are some unbelievably compelling
drug candidates,” Dr. Pacifici remarked.
“I guess the question we have to ask ourselves is: how much do we want to take
our eye off the ball?” he asked. “Imagine how tragic it would be if there was
something that collectively we, with CHDI’s involvement, could do to make those
things successful and we were distracted with something else that had much lower
probability of success.”
The HD community needs to “discipline” itself to focus on the “very best”
possibilities for treatments and avoid “diluting our efforts the way we did in the
old days” and “detracting resources.”
For a disease as complex and devasting as Huntington’s, there are no easy
answers. The HD community – affected families, scientists, advocacy
organizations, foundations, and our supporters – must continue the hard but brave
march towards therapies.
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CHDI: many 'irons in the fire'
in quest for Huntington's disease therapies
from Gene Veritas

1:21:44

CHDI: many 'irons in the fire' in quest for Huntington's disease
therapies from Gene Veritas on Vimeo.
Posted by Gene Veritas at 3:22 PM
Labels: alternative remedies , cannabidiol , CBD , CHDI Foundation , clinical trials ,
HDDW , Huntington's disease , methylene blue , presymptomatic gene carrier , Robert
Pacifici , supplements , symptoms , therapies , treatments
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